HopeStage
Back to all studies
RecruitingNCT06853587

Using genetic information to guide antidepressant choice for adolescents

About this titleRead the official source — NCT06853587
Interventional studyAges 12–17CanadaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 12 years to 17 years.

Listed locations
CalgarySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 11, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
228
Sponsor
University of Calgary
Sponsor type
University
Study type
Other
Intervention type
Other
Locations
Canada
Age range
From 12 Years to 17 Years
Official registry ID
NCT06853587
Official title
Show the full official title

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression

Recruitment & locations

Currently recruiting

Calgary

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Calgary, a university.

Who can participate?

Listed age limits: 12 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies